Latest news with #Identity-BoundBiometric
Yahoo
20-05-2025
- Business
- Yahoo
Biometric Identity and Access Management Software Solutions Provider BIO-key Announces Two Webcast Investor Presentations: Aegis Capital Thu. May 22 at 11:30am ET and Maxim Group Wed. June 4 at 11am ET
HOLMDEL, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless, Identity-Bound Biometric (IBB) authentication solutions today announces its participation at the Aegis Capital Corp. 2025 Virtual Conference on Thursday, May 22nd and the Maxim Virtual Tech Conference on Wednesday, June 4th – webcast access details provided below. Aegis Capital Virtual Conference 2025BIO-key PresentationDate/Time: Thursday, May 22, 2025, 11:30 – 11:55 a.m. ETWebcast Link: Maxim 2025 Virtual Tech Conference: BIO-key Fireside Chat with Maxim Analyst, Jack Vander AardeDate/Time: Wednesday, June 4, 2025 at 11:00 a.m. ETWebcast Link: The Maxim conference will be hosted live on M-Vest. You must sign-in or sign up to become an M-Vest member to access the event. Investors can submit questions to the moderator throughout the panel, as well as request management meetings. For more information, please contact your Aegis Capital or Maxim Group representative or email BIO-key investor relations at BKYI@ About BIO-key International, Inc. ( BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions. Engage with BIO-key Facebook – Corporate: LinkedIn – Corporate: Twitter – Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR StockTwits: BIO_keyIR Investor ContactsWilliam Jones, David CollinsCatalyst IRBKYI@ in to access your portfolio
Globe and Mail
24-04-2025
- Business
- Globe and Mail
BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024. The notification letter has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market. On April 23, 2025, the Company filed its Form 10-K for the year ended December 31, 2024 with the SEC. On April 24, 2025, the Company received notice from Nasdaq stating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter has been closed. About BIO-key International, Inc. ( BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions. Engage with BIO-key Investor Contacts William Jones, David Collins Catalyst IR BKYI@ or 212-924-9800
